COPD (n = 39) | Healthy (n = 32) | ||
---|---|---|---|
Age, yrs | 65.7 (6.8) | 55.3 (7.1) * | |
Gender (% male) | 67 | 47 | |
Smoking status (%): | Current | 31 | 31 |
Ex | 69 | 0 | |
Never | 0 | 69 | |
Pack years | 45.6 (18.9) | 37.3 (19.1) | |
FEV1, l | 1.48 (0.5) | 3.26 (0.8) * | |
FEV1,% predicted | 54.6 (15.4) | 102.4 (12.1) * | |
FVC, l | 3.12 (0.8) | 4.20 (0.9) * | |
FVC,% predicted | 89.7 (17.6) | 113.3 (14.6) * | |
FEV1 / FVC | 49.2 (13.1) | 77.5 (6.6) * | |
BMI, kg / m2 | 27.8 (5.6) | 27.4 (3.6) | |
GOLD class I/II/III/IV (%) | 2/19/16/2 | NA | |
Inhaled corticosteroids (%) | 64 | NA | |
Dose, μg BDP equivalent | 842 (978) | NA | |
Long acting β2-agonists (%) | 56 | NA | |
Long acting antimuscarinics (%) | 56 | NA |